Adagio Therapeutics Company
Adagio Therapeutics offers research and development of therapeutic pharmaceuticals related to COVID-19.
Total Funding:
466000000
Funding Status:
IPO
Founded Date:
2020-01-01
Last Funding Type:
Series C
Employee Number:
11-50
Industry:
PharmTech
Headquarters:
Waltham, Massachusetts, United States